Intraprocedural atrial tachycardia during ablation of paroxysmal atrial fibrillation: incidence, mechanisms, and clinical outcomes
Frontiers in Cardiovascular Medicine · 22.04.2026 · 13
DOI: 10.3389/fcvm.2026.1822766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.04.2026. Verfasst von Qiushi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Pacing and Electrophysiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Radiofrequency catheter ablation (RFCA) is the mainstay treatment for paroxysmal atrial fibrillation (PAF). However, the incidence, risk factors, and impact of intra-procedural atrial tachycardia (IAT) during PAF ablation remain insufficiently characterized. The purpose of this study was to explore the incidence, risk factors, electrophysiological features, and clinical outcomes of IAT.
Methods
In this single-center, prospective study, 255 patients undergoing RFCA for PAF were analyzed. IAT was defined as stable tachycardia lasting more than 2 min, either induced or spontaneous. Logistic regression identified risk factors for AT, and Kaplan–Meier analysis was used to examine its impact on long-term success.
Results
IAT occurred in 13.33% of patients. Right atrial enlargement was identified as an independent risk factor [odds ratio (OR) = 1.14, P = 0.015], and AT involving the peri-tricuspid (45%), peri-mitral (45%), roof-dependent (2.5%) and focal (7.5%) types were found. The overall 12-month sinus rhythm maintenance rate was 78.0%, with no significant difference between the AT and non-AT groups (79.4% vs. 77.8%, P = 0.84).
Conclusions
IAT was observed in 13.3% of patients undergoing PAF ablation, with macro-reentrant circuits around the tricuspid and mitral annuli being the primary mechanisms. Right atrial diameter served as a key predictor. Our data demonstrate that with successful intra-procedural identification and targeted ablation, IAT patients can achieve a 12-month prognosis similar to non-IAT patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Pacing and Electrophysiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zitieren
APA
Chen, Q., Huang, Y., Dong, Y., Fan, X., Yadav, N., Jiang, L., He, Y., Chen, Z., Zhao, W., & Zhang, F. (2026). Intraprocedural atrial tachycardia during ablation of paroxysmal atrial fibrillation: incidence, mechanisms, and clinical outcomes. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1822766
Vancouver
Chen Q, Huang Y, Dong Y, Fan X, Yadav N, Jiang L, et al. Intraprocedural atrial tachycardia during ablation of paroxysmal atrial fibrillation: incidence, mechanisms, and clinical outcomes. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1822766
BibTeX
@article{Chen2026,
author = {Chen, Qiushi and Huang, Youfu and Dong, Yan and Fan, Xuesheng and Yadav, Nishant and Jiang, Li and He, Yuan and Chen, Zhongda and Zhao, Wei and Zhang, Fengxiang},
title = {Intraprocedural atrial tachycardia during ablation of paroxysmal atrial fibrillation: incidence, mechanisms, and clinical outcomes},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1822766}
}
EUVIMED